Table: Cosmos Pharmaceutical -2021/22 group results

Cosmos Pharmaceutical

11/07/2022 07:10

Jul 11 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2022    May 31, 2021   May 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          755.41          726.42         813.50        400.00   
                               (+6.1 pct)     (+7.7 pct)    (+7.8 pct) 
  Operating       29.80           33.15          30.00         14.92   
                               (+13.9 pct)    (+0.7 pct)    (-0.4 pct) 
  Recurring       32.86           35.84          33.00         16.42   
                               (+13.5 pct)    (+0.4 pct)    (-0.5 pct) 
  Net
  Net             23.16           27.16          23.20         11.10   
                               (+26.7 pct)    (+0.2 pct)    (-1.3 pct) 
  EPS          584.76 yen      685.80 yen     585.87 yen    280.31 yen 
  Ann Div       80.00 yen       70.00 yen      85.00 yen               
  -Q2 Div       40.00 yen       27.50 yen      42.50 yen               
  -Q4 Div       40.00 yen       42.50 yen      42.50 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T